Bautista, R

Angiotensin II type AT(2) receptor mRNA expression and renal vasodilatation are increased in renal failure. [electronic resource] - Hypertension (Dallas, Tex. : 1979) Sep 2001 - 669-73 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

1524-4563

10.1161/hy09t1.096186 doi


15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid--pharmacology
5,8,11,14-Eicosatetraynoic Acid--pharmacology
Angiotensin II--pharmacology
Animals
Antihypertensive Agents--pharmacology
Arachidonic Acid--metabolism
Clotrimazole--pharmacology
Cytochrome P-450 Enzyme System--metabolism
Dose-Response Relationship, Drug
Gene Expression Regulation--drug effects
Imidazoles--pharmacology
In Vitro Techniques
Indomethacin--pharmacology
Kidney--blood supply
Losartan--pharmacology
Male
NG-Nitroarginine Methyl Ester--pharmacology
Oligopeptides--pharmacology
Pyridines--pharmacology
RNA, Messenger--drug effects
Rats
Rats, Wistar
Receptor, Angiotensin, Type 1
Receptor, Angiotensin, Type 2
Receptors, Angiotensin--genetics
Renal Insufficiency--genetics
Vasodilation--drug effects